Literature DB >> 18506929

Reactive oxygen species and chemokines: are they elevated in the esophageal mucosa of children with gastroesophageal reflux disease?

Engin Tutar1, Deniz Ertem, Goksenin Unluguzel, Sevda Tanrikulu, Goncagul Haklar, Cigdem Celikel, Evin Ademoglu, Ender Pehlivanoglu.   

Abstract

AIM: To determine the role of inflammatory cytokines and reactive oxygen species (ROS) in childhood reflux esophagitis.
METHODS: A total of 59 subjects who had complaints suggesting GERD underwent esophagogastroduodenoscopy. Endoscopic and histopathologic diagnosis of reflux esophagitis was established by Savary-Miller and Vandenplas grading systems, respectively. Esophageal biopsy specimens were taken from the esophagus 20% proximal above the esophagogastric junction for conventional histopathological examination and the measurements of ROS and cytokine levels. ROS were measured by chemiluminescence, whereas IL-8 and MCP-1 levels were determined with quantitative immunometric ELISA on esophageal tissue. Esophageal tissue ROS, IL-8 and MCP-1 levels were compared among groups with and without endoscopic/histo-pathologic esophagitis.
RESULTS: Of 59 patients 28 (47.5%) had normal esophagus whereas 31 (52.5%) had endoscopic esophagitis. In histopathological evaluation, almost 73% of the cases had mild and 6.8% had moderate degree of esophagitis. When ROS and chemokine levels were compared among groups with and without endoscopic esophagitis, statistical difference could not be found between patients with and without esophagitis. Although the levels of ROS, IL-8 and MCP-1 were found to be higher in the group with histopathological reflux esophagitis, this difference was not statistically significant.
CONCLUSION: These results suggest that the grade of esophagitis is usually mild or moderate during childhood and factors apart from ROS, IL-8 and MCP-1 may be involved in the pathogenesis of reflux esophagitis in children.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18506929      PMCID: PMC2712856          DOI: 10.3748/wjg.14.3218

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  41 in total

1.  Gastroesophageal reflux: medical treatment.

Authors:  Yvan Vandenplas
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-09       Impact factor: 2.839

2.  Experimental esophagitis induced by acid and pepsin in rabbits mimicking human reflux esophagitis.

Authors:  A Lanas; Y Royo; J Ortego; M Molina; R Sáinz
Journal:  Gastroenterology       Date:  1999-01       Impact factor: 22.682

3.  Implication of NF-kappaB in Helicobacter pylori-associated gastritis.

Authors:  H Isomoto; Y Mizuta; M Miyazaki; F Takeshima; K Omagari; K Murase; T Nishiyama; K Inoue; I Murata; S Kohno
Journal:  Am J Gastroenterol       Date:  2000-10       Impact factor: 10.864

4.  Free radicals and antioxidant systems in reflux esophagitis and Barrett's esophagus.

Authors:  Pilar Jiménez; Elena Piazuelo; M Teresa Sánchez; Javier Ortego; Fernando Soteras; Angel Lanas
Journal:  World J Gastroenterol       Date:  2005-05-14       Impact factor: 5.742

5.  Expression of nuclear factor-kappaB in Helicobacter pylori-infected gastric mucosa detected with southwestern histochemistry.

Authors:  H Isomoto; M Miyazaki; Y Mizuta; F Takeshima; K Murase; K Inoue; K Yamasaki; I Murata; T Koji; S Kohno
Journal:  Scand J Gastroenterol       Date:  2000-03       Impact factor: 2.423

6.  Increased release of interleukin-6 by oesophageal mucosa in children with reflux oesophagitis.

Authors:  G Corrado; A Zicari; M Cavaliere; P Rea; C Pacchiarotti; F Cerroni; G Pontieri; E Cardi
Journal:  Eur J Gastroenterol Hepatol       Date:  1999-08       Impact factor: 2.566

7.  Gastroesophageal reflux disease in infants: how much is predictable with questionnaires, pH-metry, endoscopy and histology?

Authors:  Silvia Salvatore; Bruno Hauser; Kris Vandemaele; Raffaele Novario; Yvan Vandenplas
Journal:  J Pediatr Gastroenterol Nutr       Date:  2005-02       Impact factor: 2.839

8.  Reflux esophagitis in humans is a free radical event.

Authors:  G J Wetscher; R A Hinder; P Klingler; M Gadenstätter; G Perdikis; P R Hinder
Journal:  Dis Esophagus       Date:  1997-01       Impact factor: 3.429

Review 9.  Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions.

Authors:  N Mukaida; A Harada; K Matsushima
Journal:  Cytokine Growth Factor Rev       Date:  1998-03       Impact factor: 7.638

Review 10.  Role of the monocyte chemoattractant protein and eotaxin subfamily of chemokines in allergic inflammation.

Authors:  A D Luster; M E Rothenberg
Journal:  J Leukoc Biol       Date:  1997-11       Impact factor: 4.962

View more
  2 in total

1.  Protective effect of Rhei Rhizoma on reflux esophagitis in rats via Nrf2-mediated inhibition of NF-κB signaling pathway.

Authors:  O Jun Kwon; Byung Kil Choo; Joo Young Lee; Min Yeong Kim; Sung Ho Shin; Bu-Il Seo; Young-Bae Seo; Man Hee Rhee; Mi-Rae Shin; Gyo-Nam Kim; Chan Hum Park; Seong-Soo Roh
Journal:  BMC Complement Altern Med       Date:  2016-01-09       Impact factor: 3.659

2.  Improvement of Inflammation through Antioxidant Pathway of Gardeniae Fructus 50% EtOH Extract (GE) from Acute Reflux Esophagitis Rats.

Authors:  Soo Hyun Kim; Mi-Rae Shin; Ah Reum Lee; Bu-Il Seo; Hae-Jin Park; Seong-Soo Roh
Journal:  Biomed Res Int       Date:  2020-02-24       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.